SNDX

NASDAQStock

Syndax Pharmaceuticals, Inc.

$23.91-0.54 (-2.21%)

52-Week Range

$8.73
$24.16

Key Stats

Market Cap

2.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Volume

1.3M

Avg Volume

1.5M

Performance

1M

+10.50%

3M

+14.89%

6M

+51.45%

YTD

+12.63%

1Y

+83.13%

3Y

+6.24%

5Y

+1.87%

Price Chart

ETF Exposure

SNDX is held by 65 ETFs

ETFFund NameWeight
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About SNDX ETF Exposure

Syndax Pharmaceuticals, Inc. (SNDX) is held by 65 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.1B, SNDX is a widely held institutional stock. The stock currently trades at $23.91. Investors can gain exposure to SNDX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SNDX, sorted by portfolio weight.